🚨Daily Exec Briefing🚨 TrumpRx will reportedly offer discounted medication directly to patients. Link: pharmexec.com/view/trump-ann…

The landscape is shifting—technology and AI are redefining how leading pharma organizations approach product launches. Is your strategy ready for the next wave of complexity and innovation? Read the Partner Perspective: hubs.li/Q03J0_3F0 #AIDrivenLaunch

Learn how Pharmaceutical Excipients through MedicinesComplete can transform the way you work Watch this webinar to learn why Pharmaceutical Excipients, available through MedicinesComplete, is essential for those involved in the development, production, control, or regulation of

🚨Daily Exec Briefing🚨 A new report states that the President has changed his mind on imposing 100% tariffs on pharma goods while negotiations to lower prices are ongoing. Link: pharmexec.com/view/trump-pau…

🚨Daily Exec Briefing🚨 Government agencies began orderly shutdowns after Congress failed to pass 2026 funding. Link: pharmexec.com/view/fda-ramif…

🚨🚨Daily Exec Briefing🚨🚨 CDC introduces shared-decision making for COVID-19 vaccinations, emphasizing informed consent and individual consultation with healthcare providers. Link: pharmexec.com/view/cdc-updat…

🚨Daily Exec Briefing🚨 FDA announced a new pilot program titled abbreviated new drug applications. Link: pharmexec.com/view/fda-domes…

🚨Daily Exec Briefing 🚨 The deadline for DSCSA compliance is approaching. For many in the industry, this moment marks the end of a long regulatory journey. Link: pharmexec.com/view/dscsa-not…

🚨Daily Exec Briefing 🚨 In the second part of Pharm Exec’s webinar series, experts discuss the changing landscape surrounding the MFN executive order. Link: pharmexec.com/view/most-favo…

🚨Daily Exec Briefing🚨 Excellergy secures $70 million to advance innovative trifunctional ECRIs, aiming to redefine allergy treatment and improve patient outcomes. Link: pharmexec.com/view/excellerg…

Success Guide – How to Turn Pharma Reps into Masters of the Message  Discover the 3-phase roadmap to transform pharma reps into confident, credible, and compliant trusted advisors who foster impactful HCP interactions.  Unlock the Roadmap: hubs.li/Q03wWTW30

pharmexec.com/view/companies…

Avinob Roy of IQVIA shares insight on how AI companions enhance decision-making, from refining disease understanding to optimizing brand strategy. What is the most exciting opportunity for AI in your organization? Check out the dedicated dialogue: hubs.li/Q03LB2zv0

🚨Daily Exec Briefing🚨 Johnson & Johnson plans to separate its orthopaedics business, creating DePuy Synthes, to enhance focus, innovation, and value for stakeholders Link: pharmexec.com/view/johnson-j…

See how real-time electronic data capture (RT-EDC) is transforming clinical trials—reducing queries, accelerating reconciliation, and improving lab efficiency. Learn more from IQVIA experts here: hubs.li/Q03MwNw10 #ClinicalResearch #DataInnovation

🚨Daily Exec Briefing🚨 The biopharmaceutical sector sees major acquisitions, enhancing capabilities in RNA therapies and rare diseases, with key players like BioCryst and Bristol Myers Squibb leading the charge. Link: pharmexec.com/view/biopharma…

🚨Daily Exec Briefing🚨 Pharmaceutical companies enhance cancer and autoimmune disease treatments through strategic collaborations, advancing innovative therapies, and improving patient outcomes. Link: pharmexec.com/view/collabora…

🚨Daily Exec Briefing🚨 The first batch of drags included in FDA's National Priority Voucher program reveal what areas the agency is focusing on for national health concerns. Link: pharmexec.com/view/medicatio…

🚨Daily Exec Briefing 🚨 Merck invests $70 billion in US operations, launching a $3 billion manufacturing site in Virginia to enhance drug production and create jobs. Link: pharmexec.com/view/merck-pla…

🚨Daily Exec Briefing🚨 Novo Nordisk will hold an Extraordinary General Meeting in November to elect new members. Link: pharmexec.com/view/novo-nord…